Skip to content

Discontinued — last reported Q3 '24

Gross Profit at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$1.01B+6.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
TEC
Bio-TechneTECH
$208.29M-2.9%
Danaher logo
DanaherDHR
$3.59B+2.3%
Agilent Technologies logo
Agilent TechnologiesA
$990M+14.3%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

The official record: Charles River Laboratories’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's gross profit?
Charles River Laboratories (CRL) reported gross profit of $349.02M in Q3 2024.
How has Charles River Laboratories's gross profit changed year-over-year?
Charles River Laboratories's gross profit decreased by 3.5% year-over-year, from $361.84M to $349.02M.